Boehringer Ingelheim announces change in the company management

Harsha Deshmukh has been appointed as a member of the Executive Board with responsibility for IT and Global Business Services with effect from February 1, 2026

02-Dec-2025

Boehringer Ingelheim has announced that the Shareholders' Committee has appointed Harsha Deshmukh as a member of the Executive Committee. Effective February 1, 2026, Harsha Deshmukh will lead IT and the Global Business Services function, focusing on the digital transformation and further development of the company's internal business services. IT and Global Business Services were previously part of the Group Functions department. They will now be set up as a separate corporate management department.

Boehringer Ingelheim

Harsha Deshmukh / Designated Member of the Executive Board of Boehringer Ingelheim with responsibility for IT and Global Business Services

"We warmly welcome Harsha Deshmukh. With his extensive experience in driving innovation, he will take us further on our transformation journey - a transformation for the benefit of patients," said Hubertus von Baumbach, Chairman of the Shareholders' Committee, on the occasion of the appointment. "We know that in this process of continuous improvement, we can rely on the proven skills, contributions and commitment of every individual in our organization. "

Shashank Deshpande, Chairman of the Board of Managing Directors, added: "It is a pleasure to welcome Harsha Deshmukh to Boehringer Ingelheim. His appointment strengthens our capacity in the important areas of IT and Services - two areas that are critical to securing our future growth."

Harsha Deshmukh joins Boehringer Ingelheim from Infineon Technologies AG in Munich, Germany, where he most recently served as Executive Vice President & Chief Information Officer. He holds degrees in Electronics, Human Resources and Global Management from the University of Mumbai, Babson College and INSEAD.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Other news from the department people

Most read news

More news from our other portals

Last viewed contents

RNA Healer receives around one million euros for the development of a liver fibrosis therapy - MHH project wins start-up funding competition organised by Lower Saxony research incubator Institute for Biomedical Translation Lower Saxony.

RNA Healer receives around one million euros for the development of a liver fibrosis therapy - MHH project wins start-up funding competition organised by Lower Saxony research incubator Institute for Biomedical Translation Lower Saxony.

New active ingredients for the treatment of heart failure - NRW-wide HI-FIVE research project launched

New active ingredients for the treatment of heart failure - NRW-wide HI-FIVE research project launched

Smart sensor tag protects sensitive goods

Smart sensor tag protects sensitive goods

Beverage industry relies on enzymatic PET recycling from CARBIOS - New purchase agreements bring French biotech company closer to production launch

Beverage industry relies on enzymatic PET recycling from CARBIOS - New purchase agreements bring French biotech company closer to production launch

Gempex and msg industry advisors cooperate in the field of AI-supported services in the GMP-regulated environment - Quality assurance more efficient, targeted and secure

Gempex and msg industry advisors cooperate in the field of AI-supported services in the GMP-regulated environment - Quality assurance more efficient, targeted and secure

Tacalyx appoints Jean Engela as Chief Executive Officer for the next phase of growth

Tacalyx appoints Jean Engela as Chief Executive Officer for the next phase of growth

NextPharma sells its logistics division to Cencora - The sale is part of the plan to position NextPharma as Europe's leading pure-play CDMO.

NextPharma sells its logistics division to Cencora - The sale is part of the plan to position NextPharma as Europe's leading pure-play CDMO.

How an Invisible “Cap” could control Electrical Synapses - New Building Blocks of Cell Communication

How an Invisible “Cap” could control Electrical Synapses - New Building Blocks of Cell Communication

A new tunable cell-sorting device with potential biomedical applications - Precise, label-free sorting of cells of various sizes possible due to a temperature-sensitive PNIPAM hydrogel array

A new tunable cell-sorting device with potential biomedical applications - Precise, label-free sorting of cells of various sizes possible due to a temperature-sensitive PNIPAM hydrogel array

Proteins in a crowd: European XFEL looks inside cells - Researchers observe in detail how the vital iron protein ferritin makes its way in highly dense environments

Proteins in a crowd: European XFEL looks inside cells - Researchers observe in detail how the vital iron protein ferritin makes its way in highly dense environments

The smell of fatty foods during pregnancy promotes obesity in offspring - The brains of the offspring show similarities to those of obese adult mice

The smell of fatty foods during pregnancy promotes obesity in offspring - The brains of the offspring show similarities to those of obese adult mice

Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions - Collaboration combines complementary scientific and technical expertise to provide seamless solutions along the entire biopharmaceutical value chain

Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions - Collaboration combines complementary scientific and technical expertise to provide seamless solutions along the entire biopharmaceutical value chain